Inactive Instrument

Press Releases Rubius Therapeutics

Equities

RUBY

US78116T1034

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

RUBIUS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-04-06	AQ
RUBIUS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	23-03-03	AQ
RUBIUS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-02-27	AQ
RUBIUS THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-02-22	AQ
RUBIUS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)	23-02-06	AQ
Rubius Therapeutics : Acquisition/Asset Disposal - Form 8-K	22-12-21	PU
RUBIUS THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets (form 8-K)	22-12-21	AQ
American Laboratory Trading & Heritage Global Partners to Host Massive Auction of Lab Equipment from Rubius Therapeutics' Cambridge Facility	22-12-21	AQ
Rubius Therapeutics : Termination of Material Agreement - Form 8-K	22-12-14	PU
RUBIUS THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	22-12-14	AQ
RUBIUS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	22-12-12	AQ
RUBIUS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-09	AQ
RUBIUS THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K)	22-11-02	AQ
Rubius Therapeutics Announces Process to Explore Strategic Alternatives and Leadership Changes	22-11-02	GL
RUBIUS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	22-10-17	AQ
Rubius Therapeutics : Accelaration/Increase of Financial Obligation - Form 8-K	22-10-13	PU
RUBIUS THERAPEUTICS, INC. : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	22-10-13	AQ
Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference	22-09-19	GL
Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference	22-09-19	AQ
RUBIUS THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits (form 8-K)	22-09-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Rubius Therapeutics

Equities

RUBY

US78116T1034

Press Releases

Filters